For the quarter ending 2026-03-31, LXRX made $21,102K in revenue. -$1,203K in net income. Net profit margin of -5.70%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenues | 21,102 | 5,493 | 14,182 | 28,866 |
| Cost of sales | 108 | 201 | 10 | 33 |
| Research and development | 12,756 | 11,314 | 18,757 | 15,747 |
| Selling, general and administrative, including stock-based compensation of 1,709 and 1,469 | 9,234 | 8,759 | 7,602 | 9,350 |
| Total operating expenses | 22,098 | 20,274 | 26,369 | 25,130 |
| Loss from operations | -996 | -14,781 | -12,187 | 3,736 |
| Interest and other expense | 1,590 | 2,031 | 2,155 | 2,318 |
| Interest income and other | 1,543 | 1,283 | 1,573 | 1,834 |
| Net loss | -1,043 | -15,529 | -12,769 | 3,252 |
| Unrealized gain on investments | -160 | 1 | 43 | -39 |
| Comprehensive loss | -1,203 | -15,528 | -12,726 | 3,213 |
| Basic EPS | 0 | -0.043 | -0.04 | 0.01 |
| Diluted EPS | 0 | -0.043 | -0.04 | 0.01 |
| Basic Average Shares | 400,240,000 | 363,446,000 | 363,399,000 | 363,294,000 |
| Diluted Average Shares | 400,240,000 | 363,170,000 | 363,399,000 | 363,570,000 |
LEXICON PHARMACEUTICALS, INC. (LXRX)
LEXICON PHARMACEUTICALS, INC. (LXRX)